Neurovascular DAPK expression and activity could be triggered in brain disorders such as TLE, AVM, and BT by various pathophysiology factors, e.g., seizure, VEGF upregulation, and hypoxic conditions (Fig. 7); these conditions could be regulated by postulating DAPK as a potential therapeutic target for future intervention. Here, VEGFA is linked to brain disorder.